XTL Biopharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XTLB and other ETFs, options, and stocks.About XTLB
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO.
CEONoam Band
CEONoam Band
Employees11
Employees11
HeadquartersRamat Gan, Tel Aviv
HeadquartersRamat Gan, Tel Aviv
Founded1993
Founded1993
Employees11
Employees11
XTLB Key Statistics
Market cap7.67M
Market cap7.67M
Price-Earnings ratio-7.25
Price-Earnings ratio-7.25
Dividend yield—
Dividend yield—
Average volume25.18K
Average volume25.18K
High today$0.824
High today$0.824
Low today$0.717
Low today$0.717
Open price$0.717
Open price$0.717
Volume24.26K
Volume24.26K
52 Week high$2.57
52 Week high$2.57
52 Week low$0.5301
52 Week low$0.5301
XTLB News
TipRanks 5d
XTL Biopharmaceuticals Faces Nasdaq Delisting After “Public Shell” DeterminationAn update from XTL Biopharmaceuticals Sponsored ADR ( (XTLB) ) is now available. On February 27, 2026, XTL Biopharmaceuticals disclosed that Nasdaq’s Listing Q...
TipRanks 5d
XTL Biopharmaceuticals gets delisting letter from Nasdaq, to request hearingXTL Biopharmaceuticals (XTLB) announced that it has received a letter from Nasdaq, dated February 25, notifying the company of the staff’s belief, based upon it...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.